Ftse Mib
34.271,12
0,00%
DAX
18.077,71
-0,36%
S&P 500
5.071,63
0,02%
NASDAQ Composite
15.712,75
0,10%
Bitcoin
64.203,33
-0,12%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistente personale
Home Investire Azioni Regno Unito LSE Idorsia Ltd (0RQE) Idorsia Ltd (0RQE) Notizie

Idorsia Ltd

0RQE
1,9775
0,00 (0,00%)
25 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: CHF

Ultime notizie

Data Ora Fonte Titolo
23/4/202407:00UKREGIdorsia publishes an invitation to a bondholder meeting
23/4/202407:00UKREGIdorsia publishes an invitation to a bondholder meeting
17/4/202407:00UKREGIdorsia publishes a Financial Status required for an..
17/4/202407:00UKREGIdorsia publishes a Financial Status required for an..
11/4/202407:00UKREGIdorsia takes steps to address short-term liquidity needs
11/4/202407:00UKREGIdorsia takes steps to address short-term liquidity needs
22/3/202407:00UKREGIdorsia thanks Guy Braunstein for his years of service as he..
22/3/202407:00UKREGIdorsia thanks Guy Braunstein for his years of service as he..
20/3/202407:00UKREGUS FDA approves Idorsia’s once-daily TRYVIO (aprocitentan) –..
20/3/202407:00UKREGUS FDA approves Idorsia’s once-daily TRYVIO (aprocitentan) –..
18/3/202407:00UKREGIdorsia and Viatris successfully close the transaction for..
18/3/202407:00UKREGIdorsia and Viatris successfully close the transaction for..
28/2/202407:00UKREGIdorsia and Viatris enter into a significant global research..
28/2/202407:00UKREGIdorsia and Viatris enter into a significant global research..
10/1/202407:00GLOBEIdorsia presents at the J.P. Morgan Healthcare Conference –..
03/11/202322:30GLOBENew Phase 3 data with aprocitentan for patients with..
24/10/202307:00GLOBEIdorsia announces financial results for the first nine..
23/10/202307:00GLOBEIdorsia is committed to further the science of sleep with a..
17/10/202317:45GLOBEInvitation to Idorsia's Nine-Month 2023 Financial Reporting..
06/9/202307:00GLOBEIdorsia reacquires the world-wide rights to aprocitentan
25/7/202307:00GLOBEIdorsia announces financial results for the first half 2023..
21/7/202307:00GLOBEIdorsia announces a cost reduction initiative to be..
20/7/202308:30GLOBEIdorsia sells its Asia Pacific (ex-China) operations –..
18/7/202317:45GLOBEInvitation to Idorsia's HY 2023 Financial Results webcast..
10/7/202307:00GLOBEIdorsia announces its insomnia medication, QUVIVIQ..
26/6/202317:45GLOBENew Phase 3 data with aprocitentan for patients with..
23/6/202317:45GLOBENew Phase 3 data with aprocitentan to be presented at the..
20/6/202307:00GLOBEIdorsia has secured bridge financing in the amount of CHF..
12/6/202307:00GLOBEIdorsia bringt QUVIVIQ (Daridorexant) in der Schweiz auf den..
06/6/202307:00GLOBEIdorsia has entered into exclusive negotiations with regard..
30/5/202307:00GLOBEIdorsia announces a change to commercial leadership
04/5/202311:16GLOBEIdorsia holds its Annual General Meeting of Shareholders
03/5/202307:00GLOBEHealth Canada approves QUVIVIQ (daridorexant) for the..
Apertura: Min: Max:
Chiusura: 1,9775

La tua Cronologia

LSE
0RQE
Idorsia
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network